Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: comment on the article by Baeten et al.
Cunnane
G
G
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D025242:Spondylarthropathies / Q000276:immunology / Q000628:therapy*; D013583:Synovial Membrane / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab